With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
Luxna Biotech & Inabata ink license agreement for manufacture and sale of modified nucleic acid GuNA amidite: Osaka, Japan Monday, March 16, 2026, 09:00 Hrs [IST] Luxna Biotech Co ...
Study to test RC220 alongside standard-of-care osimertinib to prevent or delay treatment resistance. ... Read More The post Racura secures green light for RC220 HARNESS-1 lung cancer trial appeared ...
India, March 15 -- While some fear that artificial intelligence could lead to job losses and mass layoffs, for others it is ...